PACE Large Co Value Equity A holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
PACE Large Co Value Equity Investments Class A PCPAX
- NAV / 1-Day Return 23.71 / −0.84 %
- Total Assets 791.0M
-
Adj. Expense Ratio
1.130%
- Expense Ratio 1.130%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.98%
- Turnover 55%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:17 AM GMT+0
Morningstar’s Analysis PCPAX
Will PCPAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the PCPAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of PCPAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Elevance Health Inc | 3.70 | 19M | Healthcare |
Unilever PLC ADR | 3.09 | 16M | Consumer Defensive |
T-Mobile US Inc | 2.95 | 15M | Communication Services |
Merck & Co Inc | 2.91 | 15M | Healthcare |
M&T Bank Corp | 2.82 | 14M | Financial Services |
Huntington Bancshares Inc | 2.78 | 14M | Financial Services |
Dominion Energy Inc | 2.78 | 14M | Utilities |
PPG Industries Inc | 2.77 | 14M | Basic Materials |
Gilead Sciences Inc | 2.48 | 13M | Healthcare |
Ferguson Enterprises Inc | 2.46 | 13M | Industrials |
United States